Cryo-Cell International, Inc. (NYSE:CCEL)

Friday, April 21, 2023 | Web News
Cryo-Cell International Inc (OTC:CCEL) a company that provides private and public cord blood banking solutions for stem cell treatments, announced Q1 2023 results:...
Wednesday, March 1, 2023 | Web News
Cryo-Cell International Inc (OTC:CCEL) ($3.82; $32.5M market cap), a company that provides private and public cord blood banking...
Tuesday, August 23, 2022 | Web News
Cryo-Cell International Inc (NASDAQ:CCEL) ($5.20; $43.6M market cap), a company that provides private and public cord blood banking...
See All Research...
Tuesday, May 11, 2021, 8:09 AM
Perspectives on Cryo-Cell's Position as an Industry Leader in Cord Blood Storage Services [Reasons for Tracking]
See All Articles and Reports...
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Web site: http://www.cryo-cell.com

Last updated July 30, 2008